Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
In his State of the Union address, Trump urged lawmakers to ban stock trading by Congress. The move launches a high-s...
Dell Technologies posted a billion-dollar quarter, driven by AI server orders that surged in Q4 and propelled a raise...
JPMorgan Chase CEO Jamie Dimon cautions that inflation could reappear if geopolitical shocks linger, rattling investo...
WTI crude trades near multi-year highs as supply constraints and growing demand spur a rally. Analysts say the path h...
Analysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
Cardano's ADA is set for a major upgrade while traders watch a tight price range. Regulatory clarity and cross-chain ...
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
AI-driven payroll reductions accelerate as major firms trim jobs, altering earnings and market sentiment in May 2026.
As negotiators in Beijing steer talks between the U.S. and China, investors are eyeing three names likely to move: NV...
Galaxy Research analyst Alex Thorn lifts the odds of the CLARITY Act becoming law in 2026 to 75%, citing a pivotal Se...